
Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Undisclosed
Therapeutic Area : Oncology
Study Phase : Discovery Platform
Sponsor : JSL Health Capital
Deal Size : $8.9 million
Deal Type : Financing
Synfini Adds $8.9 Million Discovery Funding to Speed Small Molecule Drug Development
Details : The proceeds will bolster company's AI Cloud Foundry platform to accelerate the discovery of novel small-molecule drug candidates.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Undisclosed
July 07, 2025
Lead Product(s) : Undisclosed
Therapeutic Area : Oncology
Highest Development Status : Discovery Platform
Sponsor : JSL Health Capital
Deal Size : $8.9 million
Deal Type : Financing
